MDXG Insider Trading
MIMEDX GROUP, INC. | Surgical & Medical Instruments & Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at MIMEDX GROUP, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-11 01:14 | 2025-11-06 | Maersk-Moller Kimberly | Officer - Chief Commercial Officer | SELL | $7.42 | 58,300 | $432,329 | 236,982 | -19.7% |
| 2025-05-05 17:06 | 2025-05-02 | Capper Joseph H | Officer - Chief Executive Officer | BUY | $6.34 | 200,000 | $1,268,000 | 529,530 | +60.7% |
| 2025-03-20 13:09 | 2025-03-17 | Maersk-Moller Kimberly | Officer - Chief Commercial Officer | SELL | $8.04 | 1,759 | $14,142 | 309,077 | -0.6% |
| 2025-03-15 00:58 | 2025-03-13 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $7.89 | 54,596 | $430,762 | 440,178 | -11.0% |
| 2025-03-15 00:56 | 2025-03-13 | Maersk-Moller Kimberly | Officer - Chief Commercial Officer | SELL | $7.89 | 4,106 | $32,396 | 310,836 | -1.3% |
| 2025-03-13 02:56 | 2025-03-10 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $7.80 | 81,446 | $635,279 | 494,774 | -14.1% |
| 2025-03-06 03:13 | 2025-02-28 | Maersk-Moller Kimberly | Officer - Chief Commercial Officer | SELL | $8.41 | 2,111 | $17,743 | 265,271 | -0.8% |
| 2025-02-19 01:36 | 2025-02-13 | Whitlow Ricci S | Officer - Chief Operating Officer | SELL | $8.28 | 61,420 | $508,558 | 403,019 | -13.2% |
| 2024-03-16 01:35 | 2024-03-13 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $7.95 | 20,381 | $162,029 | 479,959 | -4.1% |
| 2024-02-22 00:40 | 2024-02-16 | Whitlow Ricci S | Officer - Chief Operating Officer | SELL | $8.04 | 30,764 | $247,426 | 401,050 | -7.1% |
| 2024-02-17 00:22 | 2024-02-14 | Whitlow Ricci S | Officer - Chief Operating Officer | SELL | $8.05 | 31,043 | $249,763 | 431,814 | -6.7% |
| 2023-11-23 01:01 | 2023-11-21 | DOUG RICE | Officer - Chief Financial Officer | BUY | $7.16 | 5,000 | $35,787 | 102,200 | +5.1% |
| 2023-06-27 01:10 | 2023-06-22 | Capper Joseph H | Officer - Chief Executive Officer | BUY | $6.40 | 100,000 | $640,430 | 100,000 | +100.0% |
| 2023-05-18 01:26 | 2023-05-15 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $6.00 | 13,972 | $83,797 | 317,803 | -4.2% |
| 2023-05-13 01:58 | 2023-05-10 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $5.93 | 5,870 | $34,786 | 456,564 | -1.3% |
| 2023-05-13 01:56 | 2023-05-10 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $5.93 | 5,869 | $34,780 | 331,775 | -1.7% |
| 2023-05-13 01:53 | 2023-05-10 | Phelan William Lawrence | Officer - Chief Accounting Officer | SELL | $5.93 | 1,595 | $9,452 | 184,219 | -0.9% |
| 2023-05-13 01:50 | 2023-05-10 | Carlson Peter M | Officer - Chief Financial Officer | SELL | $5.93 | 5,976 | $35,414 | 656,435 | -0.9% |
| 2023-05-09 15:32 | 2023-05-04 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $5.34 | 51,756 | $276,470 | 337,644 | -13.3% |
| 2023-05-04 01:26 | 2023-05-02 | Phelan William Lawrence | Officer - Chief Accounting Officer | SELL | $3.80 | 5,200 | $19,739 | 185,814 | -2.7% |
| 2023-04-28 02:25 | 2023-04-25 | Phelan William Lawrence | Officer - Chief Accounting Officer | SELL | $3.74 | 1,628 | $6,095 | 191,014 | -0.8% |
| 2023-04-28 02:24 | 2023-04-25 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $3.74 | 5,987 | $22,415 | 389,400 | -1.5% |
| 2023-04-28 02:23 | 2023-04-25 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $3.74 | 5,988 | $22,419 | 462,434 | -1.3% |
| 2023-04-28 02:21 | 2023-04-25 | Carlson Peter M | Officer - Chief Financial Officer | SELL | $3.74 | 6,094 | $22,816 | 662,411 | -0.9% |
| 2023-04-14 00:52 | 2023-04-11 | Phelan William Lawrence | Officer - Chief Accounting Officer | SELL | $3.31 | 1,632 | $5,402 | 192,642 | -0.8% |
| 2023-04-14 00:50 | 2023-04-11 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $3.31 | 5,996 | $19,847 | 395,387 | -1.5% |
| 2023-04-14 00:39 | 2023-04-11 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $3.31 | 5,995 | $19,843 | 468,422 | -1.3% |
| 2023-04-14 00:37 | 2023-04-11 | Carlson Peter M | Officer - Chief Financial Officer | SELL | $3.31 | 6,100 | $20,191 | 668,505 | -0.9% |
| 2023-03-10 01:43 | 2023-03-07 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $4.24 | 12,355 | $52,442 | 266,318 | -4.4% |
| 2023-03-10 01:42 | 2023-03-07 | Phelan William Lawrence | Officer - Chief Accounting Officer | SELL | $4.24 | 3,396 | $14,415 | 141,244 | -2.3% |
| 2023-03-10 01:41 | 2023-03-07 | Carlson Peter M | Officer - Chief Financial Officer | SELL | $4.24 | 12,056 | $51,173 | 534,150 | -2.2% |
| 2023-03-10 01:40 | 2023-03-07 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $4.24 | 11,308 | $47,998 | 338,053 | -3.2% |
| 2023-02-25 01:41 | 2023-02-23 | Carlson Peter M | Officer - Chief Financial Officer | SELL | $4.50 | 19,000 | $85,416 | 546,206 | -3.4% |
| 2023-02-25 01:36 | 2023-02-23 | Hulse William Frank IV | Officer - General Counsel and CAO | SELL | $4.53 | 15,555 | $70,477 | 349,361 | -4.3% |
| 2022-12-28 03:55 | 2022-12-22 | Carlson Peter M | Officer - Chief Financial Officer | SELL | $2.82 | 4,992 | $14,053 | 565,206 | -0.9% |
| 2022-09-15 03:17 | 2022-09-12 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $3.44 | 27,329 | $94,069 | 278,673 | -8.9% |
| 2022-08-17 01:49 | 2022-08-12 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $4.04 | 8,503 | $34,344 | 306,002 | -2.7% |
| 2022-08-12 01:30 | 2022-08-09 | Kashyap Rohit | Officer - President, WC & Surgical | SELL | $4.21 | 12,343 | $51,939 | 430,072 | -2.8% |
| 2022-08-09 00:43 | 2022-08-04 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $3.62 | 19,500 | $70,590 | 314,505 | -5.8% |
| 2022-07-01 02:09 | 2022-06-28 | Stein Robert Benjamin | Officer - President, Regenerative Med. | SELL | $3.47 | 14,600 | $50,662 | 334,005 | -4.2% |
| 2022-06-14 01:45 | 2022-06-09 | WRIGHT TIMOTHY R | Director, Officer - Chief Executive Officer | SELL | $3.75 | 112,000 | $420,000 | 1,711,324 | -6.1% |
| 2022-05-10 23:47 | 2022-05-06 | Phelan William Lawrence | Officer - Chief Accounting Officer | SELL | $3.81 | 5,750 | $21,908 | 144,640 | -3.8% |
| 2022-05-10 23:44 | 2022-05-09 | Graves Mark | Officer - SVP & Chief Compliance Officer | SELL | $3.50 | 3,891 | $13,622 | 133,608 | -2.8% |
| 2022-05-04 23:33 | 2022-05-02 | Turner Scott M | Officer - SVP, Operations & Procurement | SELL | $4.00 | 5,260 | $21,045 | 226,643 | -2.3% |
| 2022-03-11 00:31 | 2022-03-08 | WRIGHT TIMOTHY R | Director, Officer - Chief Executive Officer | SELL | $4.86 | 45,611 | $221,624 | 1,220,645 | -3.6% |
| 2022-03-11 00:29 | 2022-03-08 | Turner Scott M | Officer - SVP, Operations & Procurement | SELL | $4.86 | 4,155 | $20,189 | 170,431 | -2.4% |
| 2022-03-11 00:28 | 2022-03-08 | Kashyap Rohit | Officer - EVP & Chief Commercial Officer | SELL | $4.86 | 8,770 | $42,613 | 263,844 | -3.2% |
| 2022-03-11 00:27 | 2022-03-08 | Graves Mark | Officer - SVP & Chief Compliance Officer | SELL | $4.86 | 3,234 | $15,714 | 89,014 | -3.5% |
| 2022-03-11 00:27 | 2022-03-08 | Carlson Peter M | Officer - Chief Financial Officer | SELL | $4.86 | 10,743 | $52,200 | 382,698 | -2.7% |
| 2022-03-11 00:25 | 2022-03-08 | Hulse William Frank IV | Officer - General Counsel | SELL | $4.86 | 9,990 | $48,541 | 186,345 | -5.1% |
How to Interpret $MDXG Trades
Not every insider transaction in MIMEDX GROUP, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MDXG shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for MDXG
Insider activity data for MIMEDX GROUP, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MDXG, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.